NTRK2 and depressive symptom measurement: The BDNF-TrkB signaling pathway may further activate transcription factors to mediate the comorbidity of addiction and depression (Arthur et al., 2004; Levine et al., 2005; Nair and Vaidya, 2006; Vialou et al., 2012).